Cargando…

MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies

Head and neck squamous cell carcinoma (HNSCC) are referred to a group of heterogeneous cancers that include structures of aerodigestive tract such as oral and nasal cavity, salivary glands, oropharynx, pharynx, larynx, paranasal sinuses, and local lymph nodes. HNSCC is characterized by frequent alte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vahabi, Mahrou, Blandino, Giovanni, Di Agostino, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Clinic and Therapeutic Potential of Non-coding RNAs in Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797920/ https://www.ncbi.nlm.nih.gov/pubmed/35116619 http://dx.doi.org/10.21037/tcr-20-2530

Ejemplares similares

Clinic and therapeutic potential of non-coding RNAs in cancer
por: Castellano, Joan Josep, et al.
Publicado: (2021)

Exosomal microRNAs in non-small cell lung cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2021)

Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role
por: Gallardo Martin, Elena, et al.
Publicado: (2021)

Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
por: De Martino, Marco, et al.
Publicado: (2021)

MicroRNAs and Xenobiotic Toxicity: An Overview
por: Balasubramanian, Satheeswaran, et al.
Publicado: (2020)

Placental microRNAs: Responders to environmental chemicals and mediators of pathophysiology of the human placenta
por: Addo, Kezia A., et al.
Publicado: (2020)

microRNAs: Potential biomarkers of toxicity: A special issue of the journal Toxicology Reports
por: Sahu, Saura C., et al.
Publicado: (2020)

Role of MicroRNAs in regulation of DNA damage in monocytes exposed to polystyrene and TiO(2) nanoparticles
por: Hu, Moyan, et al.
Publicado: (2020)

A meta-analysis of microRNAs expressed in human aerodigestive epithelial cultures and their role as potential biomarkers of exposure response to nicotine-containing products
por: Sewer, Alain, et al.
Publicado: (2020)

Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4
por: Ono, Ryuichi, et al.
Publicado: (2020)

Salvage surgery in head and neck cancer
por: van Weert, Stijn, et al.
Publicado: (2020)

Early microRNA indicators of PPARα pathway activation in the liver
por: Chorley, Brian N., et al.
Publicado: (2020)

Long Noncoding RNAs: Emerging Biomarkers of Therapy Resistance and Tumor Progression
por: Deshpande, Ravindra P.
Publicado: (2023)

Prosthodontic rehabilitation of head and neck cancer patients—Challenges and new developments
por: Vosselman, Nathalie, et al.
Publicado: (2020)

Zebrafish as an integrative vertebrate model to identify miRNA mechanisms regulating toxicity
por: Ahkin Chin Tai, Janiel K., et al.
Publicado: (2020)

The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?
por: Aloizou, Athina-Maria, et al.
Publicado: (2020)

Prokaryotic ncRNAs: Master regulators of gene expression
por: Majumder, Rajib, et al.
Publicado: (2022)

Regulatory role of miRNAs in Wnt signaling pathway linked with cardiovascular diseases
por: Behera, Jiban Kumar, et al.
Publicado: (2022)

Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
por: Ahmed, Rubai, et al.
Publicado: (2022)

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
por: Van Goethem, Alan, et al.
Publicado: (2023)

‘Denk nu vast na over het afschalen van zorg bij code zwart’
por: Hamel, Margot
Publicado: (2022)

NuHamil : A numerical code to generate nuclear two- and three-body matrix elements from chiral effective field theory
por: Miyagi, Takayuki
Publicado: (2023)

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

Comprehensive Characterization of Circular RNAs in Neuroblastoma Cell Lines
por: Zhang, Li, et al.
Publicado: (2020)

A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity
por: Huang, Weiqiang, et al.
Publicado: (2019)

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
por: Traber, Gavin M., et al.
Publicado: (2023)

Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis
por: Zhao, Sidi, et al.
Publicado: (2023)

Circular stable intronic RNAs possess distinct biological features and are deregulated in bladder cancer
por: Rasmussen, Asta M, et al.
Publicado: (2023)

Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer
por: Di Agostino, Silvia, et al.
Publicado: (2022)

Novel p53 therapies for head and neck cancer
por: Castellanos, Mario R., et al.
Publicado: (2016)

Target/therapies for chronic recurrent erythema nodosum leprosum
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016)

Translational neuroscience: the state of the nation (a PhD student perspective)
por: Davies, Caitlin, et al.
Publicado: (2020)

Conferences in the time of COVID: notes on organizing and delivering the first Brain Conference
por: Li, Lucia M, et al.
Publicado: (2021)

Gender representation in science publication: evidence from Brain Communications
por: Marescotti, Manuela, et al.
Publicado: (2022)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma
por: Bae, Woo Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5udfidpd9mol6pladjdkv829pf